Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia. | PLoS One | 2022 | 36129940 | PubTator, text mining | PubMed |
| Regulatory mechanisms and function of hypoxia-induced long noncoding RNA NDRG1-OT1 in breast cancer cells. | Cell Death Dis | 2022 | 36127332 | PubTator, text mining | PubMed |
| Malnourishment affects gene expression along the length of the small intestine. | Front Nutr | 2022 | 36118759 | PubTator, text mining | PubMed |
| Integrative analysis identifies three molecular subsets in ovarian cancer. | Clin Transl Med | 2022 | 36116137 | PubTator, text mining | PubMed |
| Recent advances and limitations of mTOR inhibitors in the treatment of cancer. | Cancer Cell Int | 2022 | 36109789 | PubTator, text mining | PubMed |
| PARP3 supervises G9a-mediated repression of adhesion and hypoxia-responsive genes in glioblastoma cells. | Sci Rep | 2022 | 36109561 | PubTator, text mining | PubMed |
RNA-sequencing and mass-spectrometry proteomic time-series analysis of T-cell differentiation identified multiple splice variants models that predicted validated protein biomarkers in inflammatory diseases. | Front Mol Biosci | 2022 | 36106020 | PubTator, text mining | PubMed |
| Long non-coding RNA colon cancer-associated transcript 2: role and function in human cancers. | Chin Med J (Engl) | 2022 | 36103972 | PubTator, text mining | PubMed |
| BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer. | Cell Rep | 2022 | 36103824 | PubTator, text mining | PubMed |
| Prognostic significance of YAP1 expression and its association with neuroendocrine markers in resected pulmonary large cell neuroendocrine carcinoma (LCNEC). | Transl Oncol | 2022 | 36103754 | PubTator, text mining | PubMed |
| Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma. | Hepatol Commun | 2022 | 36097402 | PubTator, text mining | PubMed |
| Isoform-resolved mRNA profiling of ribosome load defines interplay of HIF and mTOR dysregulation in kidney cancer. | Nat Struct Mol Biol | 2022 | 36097292 | PubTator, text mining | PubMed |
| Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction. | Int J Mol Sci | 2022 | 36077137 | PubTator, text mining | PubMed |
| Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. | Nat Cancer | 2022 | 36065066 | PubTator, text mining | PubMed |
| The overexpression of GPX8 is correlated with poor prognosis in GBM patients. | Front Genet | 2022 | 36061208 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis of the Oncogenic and Immunological Role of Solute Carrier Family 6 Member 8 (SLC6A8). | Front Genet | 2022 | 36061183 | PubTator, text mining | PubMed |
| A Novel hepatocellular carcinoma specific hypoxic related signature for predicting prognosis and therapeutic responses. | Front Immunol | 2022 | 36059442 | PubTator, text mining | PubMed |
| Disease-related protein co-expression networks are associated with the prognosis of resectable node-positive pancreatic ductal adenocarcinoma. | Sci Rep | 2022 | 36038612 | PubTator, text mining | PubMed |
| Potential factors of Helicobacter pylori resistance to clarithromycin. | Drug Metab Pers Ther | 2022 | 36027921 | PubTator, text mining | PubMed |
| ADP-ribosylation of RNA in mammalian cells is mediated by TRPT1 and multiple PARPs. | Nucleic Acids Res | 2022 | 36018800 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=31